Oncology Navigation Decreases Time to Treatment in Patients with Pancreatic Malignancy
Background Care of pancreatic cancer patients has become increasingly complex, which has led to delays in the initiation of therapy. Nurse navigators have been added to care teams, in part, to ameliorate this delay. This study investigated the difference in time from first oncology visit to first tr...
Saved in:
| Published in: | Annals of surgical oncology Vol. 26; no. 5; pp. 1512 - 1518 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Cham
Springer International Publishing
01.05.2019
Springer Nature B.V |
| Subjects: | |
| ISSN: | 1068-9265, 1534-4681, 1534-4681 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
Care of pancreatic cancer patients has become increasingly complex, which has led to delays in the initiation of therapy. Nurse navigators have been added to care teams, in part, to ameliorate this delay. This study investigated the difference in time from first oncology visit to first treatment date in patients with any pancreatic malignancy before and after the addition of an Oncology Navigator.
Methods
A single-institution database of patients with any pancreatic neoplasm evaluated by a provider in radiation, medical, or surgical oncology between 1 October 2015 and 30 September 2017 was analyzed. After 1 October 2016, an Oncology Navigator met patients at their initial visit and coordinated care throughout treatment. The cohort was divided into two groups: patients evaluated prior to the implementation of an Oncology Navigator and patients evaluated after implementation. Patient demographics and time from first visit to first intervention were compared.
Results
Overall, 147 patients with a new diagnosis of pancreatic neoplasm were evaluated; 57 patients were seen prior to the start of the Oncology Navigator program and 79 were evaluated after the navigation program was implemented. On univariate analysis, time from first contact by any provider to intervention was 46 days prior to oncology navigation and 26 days after implementation of oncology navigation (
p =
0.005). While controlling for other covariates, employment of the Oncology Navigator decreased the time from first contact by any provider to intervention by almost 16 days (
p =
0.009).
Conclusions
Implementing an oncology navigation program significantly decreased time to treatment in patients with pancreatic malignancy. |
|---|---|
| AbstractList | Background: Care of pancreatic cancer patients has become increasingly complex, which has led to delays in the initiation of therapy. Nurse navigators have been added to care teams, in part, to ameliorate this delay. This study investigated the difference in time from first oncology visit to first treatment date in patients with any pancreatic malignancy before and after the addition of an Oncology Navigator. Methods: A single-institution database of patients with any pancreatic neoplasm evaluated by a provider in radiation, medical, or surgical oncology between 1 October 2015 and 30 September 2017 was analyzed. After 1 October 2016, an Oncology Navigator met patients at their initial visit and coordinated care throughout treatment. The cohort was divided into two groups: patients evaluated prior to the implementation of an Oncology Navigator and patients evaluated after implementation. Patient demographics and time from first visit to first intervention were compared. Results: Overall, 147 patients with a new diagnosis of pancreatic neoplasm were evaluated; 57 patients were seen prior to the start of the Oncology Navigator program and 79 were evaluated after the navigation program was implemented. On univariate analysis, time from first contact by any provider to intervention was 46 days prior to oncology navigation and 26 days after implementation of oncology navigation (p = 0.005). While controlling for other covariates, employment of the Oncology Navigator decreased the time from first contact by any provider to intervention by almost 16 days (p = 0.009). Conclusions: Implementing an oncology navigation program significantly decreased time to treatment in patients with pancreatic malignancy. BackgroundCare of pancreatic cancer patients has become increasingly complex, which has led to delays in the initiation of therapy. Nurse navigators have been added to care teams, in part, to ameliorate this delay. This study investigated the difference in time from first oncology visit to first treatment date in patients with any pancreatic malignancy before and after the addition of an Oncology Navigator.MethodsA single-institution database of patients with any pancreatic neoplasm evaluated by a provider in radiation, medical, or surgical oncology between 1 October 2015 and 30 September 2017 was analyzed. After 1 October 2016, an Oncology Navigator met patients at their initial visit and coordinated care throughout treatment. The cohort was divided into two groups: patients evaluated prior to the implementation of an Oncology Navigator and patients evaluated after implementation. Patient demographics and time from first visit to first intervention were compared.ResultsOverall, 147 patients with a new diagnosis of pancreatic neoplasm were evaluated; 57 patients were seen prior to the start of the Oncology Navigator program and 79 were evaluated after the navigation program was implemented. On univariate analysis, time from first contact by any provider to intervention was 46 days prior to oncology navigation and 26 days after implementation of oncology navigation (p = 0.005). While controlling for other covariates, employment of the Oncology Navigator decreased the time from first contact by any provider to intervention by almost 16 days (p = 0.009).ConclusionsImplementing an oncology navigation program significantly decreased time to treatment in patients with pancreatic malignancy. Care of pancreatic cancer patients has become increasingly complex, which has led to delays in the initiation of therapy. Nurse navigators have been added to care teams, in part, to ameliorate this delay. This study investigated the difference in time from first oncology visit to first treatment date in patients with any pancreatic malignancy before and after the addition of an Oncology Navigator.BACKGROUNDCare of pancreatic cancer patients has become increasingly complex, which has led to delays in the initiation of therapy. Nurse navigators have been added to care teams, in part, to ameliorate this delay. This study investigated the difference in time from first oncology visit to first treatment date in patients with any pancreatic malignancy before and after the addition of an Oncology Navigator.A single-institution database of patients with any pancreatic neoplasm evaluated by a provider in radiation, medical, or surgical oncology between 1 October 2015 and 30 September 2017 was analyzed. After 1 October 2016, an Oncology Navigator met patients at their initial visit and coordinated care throughout treatment. The cohort was divided into two groups: patients evaluated prior to the implementation of an Oncology Navigator and patients evaluated after implementation. Patient demographics and time from first visit to first intervention were compared.METHODSA single-institution database of patients with any pancreatic neoplasm evaluated by a provider in radiation, medical, or surgical oncology between 1 October 2015 and 30 September 2017 was analyzed. After 1 October 2016, an Oncology Navigator met patients at their initial visit and coordinated care throughout treatment. The cohort was divided into two groups: patients evaluated prior to the implementation of an Oncology Navigator and patients evaluated after implementation. Patient demographics and time from first visit to first intervention were compared.Overall, 147 patients with a new diagnosis of pancreatic neoplasm were evaluated; 57 patients were seen prior to the start of the Oncology Navigator program and 79 were evaluated after the navigation program was implemented. On univariate analysis, time from first contact by any provider to intervention was 46 days prior to oncology navigation and 26 days after implementation of oncology navigation (p = 0.005). While controlling for other covariates, employment of the Oncology Navigator decreased the time from first contact by any provider to intervention by almost 16 days (p = 0.009).RESULTSOverall, 147 patients with a new diagnosis of pancreatic neoplasm were evaluated; 57 patients were seen prior to the start of the Oncology Navigator program and 79 were evaluated after the navigation program was implemented. On univariate analysis, time from first contact by any provider to intervention was 46 days prior to oncology navigation and 26 days after implementation of oncology navigation (p = 0.005). While controlling for other covariates, employment of the Oncology Navigator decreased the time from first contact by any provider to intervention by almost 16 days (p = 0.009).Implementing an oncology navigation program significantly decreased time to treatment in patients with pancreatic malignancy.CONCLUSIONSImplementing an oncology navigation program significantly decreased time to treatment in patients with pancreatic malignancy. Care of pancreatic cancer patients has become increasingly complex, which has led to delays in the initiation of therapy. Nurse navigators have been added to care teams, in part, to ameliorate this delay. This study investigated the difference in time from first oncology visit to first treatment date in patients with any pancreatic malignancy before and after the addition of an Oncology Navigator. A single-institution database of patients with any pancreatic neoplasm evaluated by a provider in radiation, medical, or surgical oncology between 1 October 2015 and 30 September 2017 was analyzed. After 1 October 2016, an Oncology Navigator met patients at their initial visit and coordinated care throughout treatment. The cohort was divided into two groups: patients evaluated prior to the implementation of an Oncology Navigator and patients evaluated after implementation. Patient demographics and time from first visit to first intervention were compared. Overall, 147 patients with a new diagnosis of pancreatic neoplasm were evaluated; 57 patients were seen prior to the start of the Oncology Navigator program and 79 were evaluated after the navigation program was implemented. On univariate analysis, time from first contact by any provider to intervention was 46 days prior to oncology navigation and 26 days after implementation of oncology navigation (p = 0.005). While controlling for other covariates, employment of the Oncology Navigator decreased the time from first contact by any provider to intervention by almost 16 days (p = 0.009). Implementing an oncology navigation program significantly decreased time to treatment in patients with pancreatic malignancy. Background Care of pancreatic cancer patients has become increasingly complex, which has led to delays in the initiation of therapy. Nurse navigators have been added to care teams, in part, to ameliorate this delay. This study investigated the difference in time from first oncology visit to first treatment date in patients with any pancreatic malignancy before and after the addition of an Oncology Navigator. Methods A single-institution database of patients with any pancreatic neoplasm evaluated by a provider in radiation, medical, or surgical oncology between 1 October 2015 and 30 September 2017 was analyzed. After 1 October 2016, an Oncology Navigator met patients at their initial visit and coordinated care throughout treatment. The cohort was divided into two groups: patients evaluated prior to the implementation of an Oncology Navigator and patients evaluated after implementation. Patient demographics and time from first visit to first intervention were compared. Results Overall, 147 patients with a new diagnosis of pancreatic neoplasm were evaluated; 57 patients were seen prior to the start of the Oncology Navigator program and 79 were evaluated after the navigation program was implemented. On univariate analysis, time from first contact by any provider to intervention was 46 days prior to oncology navigation and 26 days after implementation of oncology navigation ( p = 0.005). While controlling for other covariates, employment of the Oncology Navigator decreased the time from first contact by any provider to intervention by almost 16 days ( p = 0.009). Conclusions Implementing an oncology navigation program significantly decreased time to treatment in patients with pancreatic malignancy. |
| Author | Pasche, Boris C. Desnoyers, Rodwige J. Blackstock, A. William Clark, Clancy J. Shen, Perry Enomoto, Laura M. Howerton, Russell M. Levine, Edward A. Fenstermaker, Joyce |
| Author_xml | – sequence: 1 givenname: Laura M. orcidid: 0000-0003-1100-8967 surname: Enomoto fullname: Enomoto, Laura M. organization: Department of Surgery, Wake Forest Baptist Medical Center – sequence: 2 givenname: Joyce surname: Fenstermaker fullname: Fenstermaker, Joyce organization: Department of Surgery, Wake Forest Baptist Medical Center – sequence: 3 givenname: Rodwige J. surname: Desnoyers fullname: Desnoyers, Rodwige J. organization: Department of Medicine, Wake Forest Baptist Medical Center – sequence: 4 givenname: Boris C. surname: Pasche fullname: Pasche, Boris C. organization: Department of Medicine, Wake Forest Baptist Medical Center – sequence: 5 givenname: A. William surname: Blackstock fullname: Blackstock, A. William organization: Department of Radiology, Wake Forest Baptist Medical Center – sequence: 6 givenname: Russell M. surname: Howerton fullname: Howerton, Russell M. organization: Department of Surgery, Wake Forest Baptist Medical Center – sequence: 7 givenname: Clancy J. surname: Clark fullname: Clark, Clancy J. organization: Department of Surgery, Wake Forest Baptist Medical Center – sequence: 8 givenname: Edward A. surname: Levine fullname: Levine, Edward A. organization: Department of Surgery, Wake Forest Baptist Medical Center – sequence: 9 givenname: Perry surname: Shen fullname: Shen, Perry email: pshen@wakehealth.edu organization: Department of Surgery, Wake Forest Baptist Medical Center |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30652224$$D View this record in MEDLINE/PubMed https://www.osti.gov/biblio/22927809$$D View this record in Osti.gov |
| BookMark | eNp9kUtv1TAQhS1URB_wB1ggS2zYBMbvZIlaXlKhLC5sLcdxbl0ldol9QfffM21aQCy68hzrO6OZOcfkIOUUCHnO4DXjUr0pDKSQDbCuAcOUafQjcsQUfkndsgOsQbdNx7U6JMelXAEwI0A9IYcCtOKcyyPy_SL5POXtnn5xP-PW1ZgTPQt-Ca6EQjdxDrRmukFd55AqjYl-RQrLQn_Feokq3dA1evrZTXGbUO-fksejm0p4dveekG_v321OPzbnFx8-nb49b7wEUZtWGwVm9I5pPng19GOQTvRgpGeqZ4L3qBSA6kbej93AR3Aj69t-kAOD1ogT8nLtm0uNtvhYg7_0OaXgq-W846aFDqlXK3W95B-7UKqdY_FhmlwKeVcsZ6YTWmr1T8M_6FXeLQl3QAqn5ZobidSLO2rXz2Gw10uc3bK393dFoF0Bv-RSljBaHO32uHVxcbIM7E2Edo3QYoT2NkKr0cr_s953f9AkVlNBOG3D8nfsB1y_ATmHrHA |
| CitedBy_id | crossref_primary_10_1542_peds_2021_054634 crossref_primary_10_1186_s12875_019_1056_y crossref_primary_10_1186_s12913_024_11483_1 crossref_primary_10_1007_s10549_023_07049_0 crossref_primary_10_1016_j_jss_2025_04_043 crossref_primary_10_1245_s10434_019_07427_3 crossref_primary_10_1002_cam4_5882 crossref_primary_10_1002_jso_27901 crossref_primary_10_1016_j_jss_2020_03_034 crossref_primary_10_1245_s10434_021_10909_y crossref_primary_10_1016_j_anr_2021_10_001 crossref_primary_10_1245_s10434_022_11971_w crossref_primary_10_1186_s12913_022_07625_y crossref_primary_10_1245_s10434_019_08003_5 crossref_primary_10_1007_s11912_024_01514_9 |
| Cites_doi | 10.1093/jnci/dju115 10.1002/cncr.23960 10.1093/oxfordjournals.annonc.a058365 10.1097/SLA.0b013e318211cc0f 10.1016/j.ypmed.2006.08.001 10.1002/cncr.24836 10.1002/cncr.28024 10.1097/01.NAJ.0000406404.80894.5a 10.1111/j.1572-0241.2005.00319.x 10.1016/j.jamcollsurg.2017.02.017 10.1097/SLA.0000000000001924 10.1089/jwh.2014.5111 10.4240/wjgs.v2.i10.314 10.1046/j.1523-5394.1999.07308.x 10.1002/cncr.22354 10.1007/s00432-012-1156-8 10.1007/s00520-014-2407-9 |
| ContentType | Journal Article |
| Copyright | Society of Surgical Oncology 2019 Annals of Surgical Oncology is a copyright of Springer, (2019). All Rights Reserved. |
| Copyright_xml | – notice: Society of Surgical Oncology 2019 – notice: Annals of Surgical Oncology is a copyright of Springer, (2019). All Rights Reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TO 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 OTOTI |
| DOI | 10.1245/s10434-019-07157-6 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) Proquest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic OSTI.GOV |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Oncogenes and Growth Factors Abstracts MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1534-4681 |
| EndPage | 1518 |
| ExternalDocumentID | 22927809 30652224 10_1245_s10434_019_07157_6 |
| Genre | Clinical Trial Journal Article |
| GroupedDBID | --- -53 -5E -5G -BR -EM -~C .86 .VR 06C 06D 0R~ 0VY 199 1N0 203 23M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2WC 2~H 30V 4.4 406 408 409 40D 40E 53G 5GY 5VS 67Z 6J9 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANZL AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABUWG ABUWZ ABWNU ABXPI ACAOD ACDTI ACGFO ACGFS ACHSB ACHVE ACHXU ACIHN ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEAQA AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFJLC AFKRA AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BAWUL BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CCPQU CS3 CSCUP DDRTE DIK DL5 DNIVK DPUIP E3Z EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GX1 GXS H13 HEOXT HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HZ~ I09 IH2 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH L7B LAS LLZTM M1P M4Y MA- N9A NB0 NPVJJ NQJWS NU0 O93 O9G O9I O9J OAM OWW P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV ROL RPX RRX RSV S16 S27 S37 S3B SAP SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOQ YFH YLTOR Z45 Z7U Z7X Z82 Z83 Z87 Z8O Z8V Z91 ZMTXR ZOVNA -Y2 1SB 28- 2P1 2VQ 5QI AANXM AAPKM AARHV AAYTO AAYXX ABBRH ABDBE ABFSG ABQSL ABRTQ ABULA ACBXY ACSTC ACUDM ADHKG AEBTG AEFIE AEKMD AEZWR AFDZB AFEXP AFFHD AFHIU AFOHR AGGDS AGQPQ AHPBZ AHWEU AIXLP AJBLW ATHPR AYFIA BBWZM C1A CAG CITATION COF EN4 FEDTE GRRUI HVGLF KOW N2Q NDZJH O9- OVD PHGZM PHGZT PJZUB PPXIY R4E RNI RZK S1Z S26 S28 SCLPG SDE T16 TEORI CGR CUY CVF ECM EIF NPM 3V. 7TO 7XB 8FK H94 K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO AAFGU AAPBV ABFGW ABKAS ACBMV ACBRV ACBYP ACIGE ACIPQ ACTTH ACVWB ACWMK ADMDM AEFTE AESTI AEVTX AGGBP AIMYW AJDOV AKQUC OTOTI UNUBA Z5O Z7V Z7W Z81 |
| ID | FETCH-LOGICAL-c403t-867507fca162dc5dbfe4a3b074c15b132ba3b50059f2bf9d2f0af1b8bd4d10873 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 21 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000464726300051&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1068-9265 1534-4681 |
| IngestDate | Thu May 18 22:41:59 EDT 2023 Mon Sep 08 07:05:11 EDT 2025 Wed Nov 05 14:50:44 EST 2025 Thu Apr 03 07:06:58 EDT 2025 Sat Nov 29 03:27:58 EST 2025 Tue Nov 18 21:21:07 EST 2025 Fri Feb 21 02:44:57 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c403t-867507fca162dc5dbfe4a3b074c15b132ba3b50059f2bf9d2f0af1b8bd4d10873 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| ORCID | 0000-0003-1100-8967 |
| PMID | 30652224 |
| PQID | 2167526274 |
| PQPubID | 32486 |
| PageCount | 7 |
| ParticipantIDs | osti_scitechconnect_22927809 proquest_miscellaneous_2179364657 proquest_journals_2167526274 pubmed_primary_30652224 crossref_citationtrail_10_1245_s10434_019_07157_6 crossref_primary_10_1245_s10434_019_07157_6 springer_journals_10_1245_s10434_019_07157_6 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-05-01 |
| PublicationDateYYYYMMDD | 2019-05-01 |
| PublicationDate_xml | – month: 05 year: 2019 text: 2019-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Cham |
| PublicationPlace_xml | – name: Cham – name: United States – name: New York |
| PublicationTitle | Annals of surgical oncology |
| PublicationTitleAbbrev | Ann Surg Oncol |
| PublicationTitleAlternate | Ann Surg Oncol |
| PublicationYear | 2019 |
| Publisher | Springer International Publishing Springer Nature B.V |
| Publisher_xml | – name: Springer International Publishing – name: Springer Nature B.V |
| References | SingalVSingalAKKuoYFRacial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysisJ Cancer Res Clin Oncol2012138471572210.1007/s00432-012-1156-822246279 McKennaLREdilBHUpdate on pancreatic neuroendocrine tumorsGland Surg201434258275254932584244504 BilimoriaKYKoCYTomlinsonJSWait times for cancer surgery in the United States: trends and predictors of delaysAnn Surg2011253477978510.1097/SLA.0b013e318211cc0f21475020 RiallTSTownsendCMJrKuoYFFreemanJLGoodwinJSDissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step processCancer2010116493093910.1002/cncr.24836200527262819626 RosenbergKPatient navigators improve colorectal cancer screening ratesAm J Nurs2011111101510.1097/01.NAJ.0000406404.80894.5a21955895 ThomasAAGallagherPO’CeilleachairAPearceASharpLMolchoMDistance from treating hospital and colorectal cancer survivors’ quality of life: a gendered analysisSupport Care Cancer201523374175110.1007/s00520-014-2407-925179691 Cancer Stat Facts: Pancreatic Cancer. https://seer.cancer.gov/statfacts/html/pancreas.html. Accessed May 2018. LidskyMESunZNussbaumDPAdamMASpeicherPJBlazerDG3rdGoing the extra mile: improved survival for pancreatic cancer patients traveling to high-volume centersAnn Surg2017266233333810.1097/SLA.000000000000192427429020 RapoportYKreitlerSChaitchikSAlgorRWeisslerKPsychosocial problems in head-and-neck cancer patients and their change with time since diagnosisAnn Oncol199341697310.1093/oxfordjournals.annonc.a0583651:STN:280:DyaK3s7mvVKrsg%3D%3D8435366 Institute of Medicine (US) Committee on Quality of Health Care in AmericaCrossing the quality chasm: a new health system for the 21st century2001Washington (DC)National Academies Press (US) FazioLCotterchioMMannoMMcLaughlinJGallingerSAssociation between colonic screening, subject characteristics, and stage of colorectal cancerAm J Gastroenterol2005100112531253910.1111/j.1572-0241.2005.00319.x16279911 GrayREFitchMIPhillipsCLabrecqueMKlotzLPresurgery experiences of prostate cancer patients and their spousesCancer Pract19997313013510.1046/j.1523-5394.1999.07308.x1:STN:280:DyaK1M3otVChsA%3D%3D10352075 FreundKMBattagliaTACalhounENational Cancer Institute Patient Navigation Research Program: methods, protocol, and measuresCancer2008113123391339910.1002/cncr.23960189515212698219 BattagliaTARoloffKPosnerMAFreundKMImproving follow-up to abnormal breast cancer screening in an urban population. A patient navigation interventionCancer20071092 Suppl35936710.1002/cncr.2235417123275 JonesRVGreenwoodBBreast cancer: causes of patients’ distress identified by qualitative analysisBr J General Pract1994443853703711:STN:280:DyaK2czkslCgug%3D%3D WhiteMGApplewhiteMKKaplanELAngelosPHuoDGroganRHA tale of two cancers: traveling to treat pancreatic and thyroid cancerJ Am Coll Surg2017225112513610.1016/j.jamcollsurg.2017.02.01728473189 BasuMLinebargerJGabramSGPattersonSGAminMWardKCThe effect of nurse navigation on timeliness of breast cancer care at an academic comprehensive cancer centerCancer2013119142524253110.1002/cncr.2802423585059 EllKVourlekisBLeePJXieBPatient navigation and case management following an abnormal mammogram: a randomized clinical trialPrev Med2007441263310.1016/j.ypmed.2006.08.00116962652 FreundKMBattagliaTACalhounEImpact of patient navigation on timely cancer care: the Patient Navigation Research ProgramJ Natl Cancer Inst20141066dju11510.1093/jnci/dju115249383034072900 LuckettRPenaNVitonisABernsteinMRFeldmanSEffect of patient navigator program on no-show rates at an academic referral colposcopy clinicJ Womens Health (Larchmt)201524760861510.1089/jwh.2014.5111 KhanSSclabasGReid-LombardoKMPopulation-based epidemiology, risk factors and screening of intraductal papillary mucinous neoplasm patientsWorld J Gastrointest Surg201021031431810.4240/wjgs.v2.i10.314211608362999209 RE Gray (7157_CR6) 1999; 7 K Rosenberg (7157_CR10) 2011; 111 LR McKenna (7157_CR2) 2014; 3 TA Battaglia (7157_CR14) 2007; 109 V Singal (7157_CR21) 2012; 138 7157_CR1 KM Freund (7157_CR9) 2008; 113 L Fazio (7157_CR17) 2005; 100 Y Rapoport (7157_CR5) 1993; 4 AA Thomas (7157_CR16) 2015; 23 RV Jones (7157_CR4) 1994; 44 TS Riall (7157_CR20) 2010; 116 S Khan (7157_CR3) 2010; 2 K Ell (7157_CR13) 2007; 44 ME Lidsky (7157_CR19) 2017; 266 M Basu (7157_CR11) 2013; 119 MG White (7157_CR18) 2017; 225 Institute of Medicine (US) Committee on Quality of Health Care in America (7157_CR8) 2001 R Luckett (7157_CR12) 2015; 24 KY Bilimoria (7157_CR7) 2011; 253 KM Freund (7157_CR15) 2014; 106 31087181 - Ann Surg Oncol. 2019 Dec;26(Suppl 3):608-609 |
| References_xml | – reference: EllKVourlekisBLeePJXieBPatient navigation and case management following an abnormal mammogram: a randomized clinical trialPrev Med2007441263310.1016/j.ypmed.2006.08.00116962652 – reference: McKennaLREdilBHUpdate on pancreatic neuroendocrine tumorsGland Surg201434258275254932584244504 – reference: Institute of Medicine (US) Committee on Quality of Health Care in AmericaCrossing the quality chasm: a new health system for the 21st century2001Washington (DC)National Academies Press (US) – reference: BilimoriaKYKoCYTomlinsonJSWait times for cancer surgery in the United States: trends and predictors of delaysAnn Surg2011253477978510.1097/SLA.0b013e318211cc0f21475020 – reference: FreundKMBattagliaTACalhounENational Cancer Institute Patient Navigation Research Program: methods, protocol, and measuresCancer2008113123391339910.1002/cncr.23960189515212698219 – reference: BasuMLinebargerJGabramSGPattersonSGAminMWardKCThe effect of nurse navigation on timeliness of breast cancer care at an academic comprehensive cancer centerCancer2013119142524253110.1002/cncr.2802423585059 – reference: FazioLCotterchioMMannoMMcLaughlinJGallingerSAssociation between colonic screening, subject characteristics, and stage of colorectal cancerAm J Gastroenterol2005100112531253910.1111/j.1572-0241.2005.00319.x16279911 – reference: BattagliaTARoloffKPosnerMAFreundKMImproving follow-up to abnormal breast cancer screening in an urban population. A patient navigation interventionCancer20071092 Suppl35936710.1002/cncr.2235417123275 – reference: FreundKMBattagliaTACalhounEImpact of patient navigation on timely cancer care: the Patient Navigation Research ProgramJ Natl Cancer Inst20141066dju11510.1093/jnci/dju115249383034072900 – reference: KhanSSclabasGReid-LombardoKMPopulation-based epidemiology, risk factors and screening of intraductal papillary mucinous neoplasm patientsWorld J Gastrointest Surg201021031431810.4240/wjgs.v2.i10.314211608362999209 – reference: JonesRVGreenwoodBBreast cancer: causes of patients’ distress identified by qualitative analysisBr J General Pract1994443853703711:STN:280:DyaK2czkslCgug%3D%3D – reference: WhiteMGApplewhiteMKKaplanELAngelosPHuoDGroganRHA tale of two cancers: traveling to treat pancreatic and thyroid cancerJ Am Coll Surg2017225112513610.1016/j.jamcollsurg.2017.02.01728473189 – reference: GrayREFitchMIPhillipsCLabrecqueMKlotzLPresurgery experiences of prostate cancer patients and their spousesCancer Pract19997313013510.1046/j.1523-5394.1999.07308.x1:STN:280:DyaK1M3otVChsA%3D%3D10352075 – reference: ThomasAAGallagherPO’CeilleachairAPearceASharpLMolchoMDistance from treating hospital and colorectal cancer survivors’ quality of life: a gendered analysisSupport Care Cancer201523374175110.1007/s00520-014-2407-925179691 – reference: RiallTSTownsendCMJrKuoYFFreemanJLGoodwinJSDissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step processCancer2010116493093910.1002/cncr.24836200527262819626 – reference: LuckettRPenaNVitonisABernsteinMRFeldmanSEffect of patient navigator program on no-show rates at an academic referral colposcopy clinicJ Womens Health (Larchmt)201524760861510.1089/jwh.2014.5111 – reference: RosenbergKPatient navigators improve colorectal cancer screening ratesAm J Nurs2011111101510.1097/01.NAJ.0000406404.80894.5a21955895 – reference: RapoportYKreitlerSChaitchikSAlgorRWeisslerKPsychosocial problems in head-and-neck cancer patients and their change with time since diagnosisAnn Oncol199341697310.1093/oxfordjournals.annonc.a0583651:STN:280:DyaK3s7mvVKrsg%3D%3D8435366 – reference: Cancer Stat Facts: Pancreatic Cancer. https://seer.cancer.gov/statfacts/html/pancreas.html. Accessed May 2018. – reference: LidskyMESunZNussbaumDPAdamMASpeicherPJBlazerDG3rdGoing the extra mile: improved survival for pancreatic cancer patients traveling to high-volume centersAnn Surg2017266233333810.1097/SLA.000000000000192427429020 – reference: SingalVSingalAKKuoYFRacial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysisJ Cancer Res Clin Oncol2012138471572210.1007/s00432-012-1156-822246279 – volume: 106 start-page: dju115 issue: 6 year: 2014 ident: 7157_CR15 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/dju115 – volume: 3 start-page: 258 issue: 4 year: 2014 ident: 7157_CR2 publication-title: Gland Surg – volume: 113 start-page: 3391 issue: 12 year: 2008 ident: 7157_CR9 publication-title: Cancer doi: 10.1002/cncr.23960 – volume: 4 start-page: 69 issue: 1 year: 1993 ident: 7157_CR5 publication-title: Ann Oncol doi: 10.1093/oxfordjournals.annonc.a058365 – volume: 253 start-page: 779 issue: 4 year: 2011 ident: 7157_CR7 publication-title: Ann Surg doi: 10.1097/SLA.0b013e318211cc0f – volume: 44 start-page: 26 issue: 1 year: 2007 ident: 7157_CR13 publication-title: Prev Med doi: 10.1016/j.ypmed.2006.08.001 – volume: 116 start-page: 930 issue: 4 year: 2010 ident: 7157_CR20 publication-title: Cancer doi: 10.1002/cncr.24836 – volume: 119 start-page: 2524 issue: 14 year: 2013 ident: 7157_CR11 publication-title: Cancer doi: 10.1002/cncr.28024 – ident: 7157_CR1 – volume-title: Crossing the quality chasm: a new health system for the 21st century year: 2001 ident: 7157_CR8 – volume: 111 start-page: 15 issue: 10 year: 2011 ident: 7157_CR10 publication-title: Am J Nurs doi: 10.1097/01.NAJ.0000406404.80894.5a – volume: 100 start-page: 2531 issue: 11 year: 2005 ident: 7157_CR17 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2005.00319.x – volume: 225 start-page: 125 issue: 1 year: 2017 ident: 7157_CR18 publication-title: J Am Coll Surg doi: 10.1016/j.jamcollsurg.2017.02.017 – volume: 266 start-page: 333 issue: 2 year: 2017 ident: 7157_CR19 publication-title: Ann Surg doi: 10.1097/SLA.0000000000001924 – volume: 24 start-page: 608 issue: 7 year: 2015 ident: 7157_CR12 publication-title: J Womens Health (Larchmt) doi: 10.1089/jwh.2014.5111 – volume: 2 start-page: 314 issue: 10 year: 2010 ident: 7157_CR3 publication-title: World J Gastrointest Surg doi: 10.4240/wjgs.v2.i10.314 – volume: 44 start-page: 370 issue: 385 year: 1994 ident: 7157_CR4 publication-title: Br J General Pract – volume: 7 start-page: 130 issue: 3 year: 1999 ident: 7157_CR6 publication-title: Cancer Pract doi: 10.1046/j.1523-5394.1999.07308.x – volume: 109 start-page: 359 issue: 2 Suppl year: 2007 ident: 7157_CR14 publication-title: Cancer doi: 10.1002/cncr.22354 – volume: 138 start-page: 715 issue: 4 year: 2012 ident: 7157_CR21 publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-012-1156-8 – volume: 23 start-page: 741 issue: 3 year: 2015 ident: 7157_CR16 publication-title: Support Care Cancer doi: 10.1007/s00520-014-2407-9 – reference: 31087181 - Ann Surg Oncol. 2019 Dec;26(Suppl 3):608-609 |
| SSID | ssj0017305 |
| Score | 2.3896353 |
| Snippet | Background
Care of pancreatic cancer patients has become increasingly complex, which has led to delays in the initiation of therapy. Nurse navigators have been... Care of pancreatic cancer patients has become increasingly complex, which has led to delays in the initiation of therapy. Nurse navigators have been added to... BackgroundCare of pancreatic cancer patients has become increasingly complex, which has led to delays in the initiation of therapy. Nurse navigators have been... Background: Care of pancreatic cancer patients has become increasingly complex, which has led to delays in the initiation of therapy. Nurse navigators have... |
| SourceID | osti proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1512 |
| SubjectTerms | Adenocarcinoma - psychology Adenocarcinoma - therapy Aged Demography DIAGNOSIS Female Follow-Up Studies Health Services Accessibility Humans Male Malignancy Medicine Medicine & Public Health NEOPLASMS Neuroendocrine Tumors - psychology Neuroendocrine Tumors - therapy Oncology PANCREAS Pancreatic cancer Pancreatic Intraductal Neoplasms - psychology Pancreatic Intraductal Neoplasms - therapy Pancreatic Neoplasms - psychology Pancreatic Neoplasms - therapy Pancreatic Tumors Patient Navigation - methods Patient Navigation - statistics & numerical data PATIENTS Power, Psychological Prognosis RADIOLOGY AND NUCLEAR MEDICINE Retrospective Studies SURGERY Surgical Oncology THERAPY Time-to-Treatment Tumors |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JT9wwFLbotKq4lNKNoVAZqbc2auLES06ooiAuTDkAmpsVbwipSigJSPz7vuc4g6q2XHqMbEdO3uLv-W2EfGwcL5mxLPNMgoHiCpMZpXhW58KBwixU40JsNiEXC7Vc1qfpwq1PYZWTToyK2nUW78i_sAKgLcNOMfvXPzPsGoXe1dRC4wl5im2zsXa-XK4MrgK4l0dvpwChZoKnpBlWcUydq0qMv4gpPFxm4reDadaBgP0NdP7hMI3n0NHG_37BS_IiIVD6dWSZTbLm21fk-Unysb8mF9_bWMn6ni6au1iAo2vpt4gue99TzBmhQ0fPpgh1etXS07E6a0_xWhee2hGLWnoCMP8Sa3rcvyHnR4dnB8dZ6r6Q2Sovh0zBbnMZbFMI5ix3JviqKQ1ADltwA0asgSeOyauBmVA7FvImFEYZBxTPlSzfklnbtX6LUGZEY2webLAA2Jw02BnUK-OD9bZkfk6K6ddrm0qTY4eMHxpNFCCXHsmlgVw6kkuLOfm0WnM9FuZ4dPYOUlQDrMDauBaDiOygGauZVHkNwxPJdJLhXj_Qa072VsMgfehSaVrf3eIc0G-iElzOybuRQ1a7AWMMwC2D1Z8nlnl4-b-3uv34Xt6TdRa5FmMud8hsuLn1u-SZvRuu-psPkf9_AXo5CTw priority: 102 providerName: ProQuest |
| Title | Oncology Navigation Decreases Time to Treatment in Patients with Pancreatic Malignancy |
| URI | https://link.springer.com/article/10.1245/s10434-019-07157-6 https://www.ncbi.nlm.nih.gov/pubmed/30652224 https://www.proquest.com/docview/2167526274 https://www.proquest.com/docview/2179364657 https://www.osti.gov/biblio/22927809 |
| Volume | 26 |
| WOSCitedRecordID | wos000464726300051&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1534-4681 dateEnd: 20191231 omitProxy: false ssIdentifier: ssj0017305 issn: 1068-9265 databaseCode: 7X7 dateStart: 20190101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1534-4681 dateEnd: 20191231 omitProxy: false ssIdentifier: ssj0017305 issn: 1068-9265 databaseCode: BENPR dateStart: 20190101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLink Journals customDbUrl: eissn: 1534-4681 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017305 issn: 1068-9265 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEB6STSl9adIz2ySLCn1rDbZsHX5sc5CXbJY0DfsmrKsEil1iJ5B_n5FsbylNA8mLQehAjGakbzwXwKfKspxqQxNHBSooNtOJlpIlZcotXpiZrKyPxSbEfC6Xy3IxBIW1o7f7aJKMN3XMgFCwEOxW5MFjIgbdMJHwddjA504GcTz7frGyHSDPsmjj5CjKlLMhVOb-Nf56jiYNitV9UPMfM2l8fY42n7bvLXg5oE3ytWePV7Dm6tfw_GSwp7-Bi9M6Zq2-JfPqJibbaGpyEJFk61oS4kNI15Dz0RudXNZk0WdibUn4hYutusedhpwgpP8Z8nfcvoUfR4fn-8fJUGkhMUWad4lEtSEV3lQZp9Ywq70rqlwjvDAZ06iwamyxEKjqqfalpT6tfKaltni6qRT5O5jUTe22gVDNK21Sb7xBcGaFDlVAndTOG2dy6qaQjQRXZkhDHqph_FJBHUGCqZ5gCgmmIsEUn8Ln1ZzffRKOB0fvhnNUCCFCHlwTHIZMpygtqZBpid3j-apBXltFM6QADXWIpvBx1Y2SFswnVe2a6zAG7zJecCam8L7ni9VuUPFCIEtx9peRCf4s_v-tfnjc8B14QSMfBX_LXZh0V9duD56Zm-6yvZrBuliK-JUz2Ph2OF-czaJk3AG1oQLL |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VBVEuvB8LBYwEJ4hInHWcHBBClKpVu0sPC9qbG7-qSigpTVq0f4rfyIyTbIWA3nrgaDm27Pib8YznBfCytCLl2vDIcYkKik10pPNcREWcWWSYSV5aH4pNyNksXyyK_TX4OcTCkFvlwBMDo7a1oTfytzxB0ZZTpZj3x98jqhpF1tWhhEYHi123_IEqW_NuZxPP9xXnW5_mH7ejvqpAZCZx2kY5zhNLb8ok49YIq72blKnGq9QkQqNyprElKCjTc-0Ly31c-kTn2uJO4lymOO8VuIp8XJILmVysFLwEqUUE62qGTIRnog_S4RNBoXqTlPw9QsiQkFH220U4qpGg_ybk_mGgDffe1q3_7Y_dhpu9hM0-dCRxB9ZcdReuT3sfgnvw9XMVMnUv2aw8CwlG6optBum5cQ2jmBjW1mw-eOCzo4rtd9lnG0bP1tiqOlnbsCmqMYeUs2R5H75cyq4ewKiqK_cIGNdZqU3sjTcokFqpqfKpy7XzxpmUuzEkw1Er06depwog3xSpYAgP1cFDITxUgIfKxvB6Nea4Szxy4dcbhCCFYhPl_jXkJGVaxXnBZR4X2D1ARPU8qlHn-BjDi1U3chcyGZWVq0_pG-Tf2SQTcgwPO0SuVoPKJgrvHEe_GSB6Pvm_l_r44rU8h_Xt-XRP7e3Mdp_ADR4ohvxLN2DUnpy6p3DNnLVHzcmzQHsMDi4bur8AKCZnJQ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VBVW98H4sFDASnCBq4qzj5IAQYllRlS57KGhvJn6hSlVSmrRo_xq_jhkn2QoBvfXA0XJs2fE34xnPC-B5aUXKteGR4xIVFJvoSOe5iIo4s8gwk7y0PhSbkPN5vlwWiw34OcTCkFvlwBMDo7a1oTfyHZ6gaMupUsyO790iFtPZm-PvEVWQIkvrUE6jg8ieW_1A9a15vTvFs37B-ez9wbsPUV9hIDKTOG2jHOeMpTdlknFrhNXeTcpU47VqEqFRUdPYEhSg6bn2heU-Ln2ic21xV3EuU5z3ClyVaSqpbIRcrpW9BClHBEtrhgyFZ6IP2OETQWF7k5R8P0L4kJBR9tulOKqRuP8m8P5hrA134OzG__z3bsL1XvJmbztSuQUbrroNm_u9b8Ed-PKpChm8V2xenoXEI3XFpkGqblzDKFaGtTU7GDzz2WHFFl1W2obRcza2qk4GN2wf1ZtvlMtkdRc-X8qu7sGoqiv3ABjXWalN7I03KKhaqakiqsu188aZlLsxJMOxK9OnZKfKIEeKVDOEiuqgohAqKkBFZWN4uR5z3CUkufDrbUKTQnGKcgIbcp4yreK84DKPC-we4KJ63tWoc6yM4dm6G7kOmZLKytWn9A3y9WySCTmG-x0616tBJRSFeo6jXw1wPZ_830t9ePFansImIlZ93J3vPYItHoiH3E63YdSenLrHcM2ctYfNyZNAhgy-XjZyfwFpwW_Z |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oncology+Navigation+Decreases+Time+to+Treatment+in+Patients+with+Pancreatic+Malignancy&rft.jtitle=Annals+of+surgical+oncology&rft.au=Enomoto%2C+Laura+M.&rft.au=Fenstermaker%2C+Joyce&rft.au=Desnoyers%2C+Rodwige+J.&rft.au=Pasche%2C+Boris+C.&rft.date=2019-05-01&rft.issn=1068-9265&rft.eissn=1534-4681&rft.volume=26&rft.issue=5&rft.spage=1512&rft.epage=1518&rft_id=info:doi/10.1245%2Fs10434-019-07157-6&rft.externalDBID=n%2Fa&rft.externalDocID=10_1245_s10434_019_07157_6 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1068-9265&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1068-9265&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1068-9265&client=summon |